BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 25, 2002
View Archived Issues
Gilead Files NDA For Hepatitis B Product, Seeks Priority Review
Gilead Sciences Inc. on Thursday filed a new drug application with the FDA for a hepatitis B drug expected to capture a sizeable portion of the market. (BioWorld Today)
Read More
NeuroSearch, Grupo Ferrer Drop GABA Anxiety Drug In Phase I
Read More
Princeton Team Blows E. coli’s Cover, Reveals Germ’s Biofilm Formation, Predicts Antibiotics
Read More
House Committee Pursues ImClone, Wants Family Contacts
Read More
Other News To Note
Read More
Aphton Sells 1.2M Shares, Raises $12.6M For Trials, Operations
Read More
Quarterly Earnings Reports
Read More